Disseminated Aspergillosis in Intensive Care Unit Patients: An Autopsy Study

References

• Beck-Sague C, Jarvis WR. Secular trends in the epidemi-ology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis 1993; 167: 1247–1251.
   PubMed Web of Science ®Google Scholar
• Patterson TF, Kirkpatrick WR, White M et al. Invasive aspergillosis. Disease spectrum, treatment practices, and out-comes. 13 Aspergillus Study Group. Medicine (Baltimore) 2000; 79: 250–260.
   Google Scholar
• Bodey G, Bueltmann B, Duguid W et al. Fungal infec-tions in cancer patients: an international autopsy survey. Eur J Clin Microbiol Infect Dis 1992; 11: 99–109.
   Google Scholar
• Kaiser L, Huguenin T, Lew PD, Chapuis B, Pittet D. Invasive aspergillosis. Clinical features of 35 proven cases at a single institution. Medicine (Baltimore) 1998; 77: 188–194.
   Google Scholar
• Manuel RJ, Kibbler CC. The epidemiology and preven-tion of invasive aspergillosis. J Hosp Infect 1998; 39: 95–109.
   PubMed Web of Science ®Google Scholar
• Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K. Trends in the postmortem epidemiol-ogy of invasive fungal infections at a university hospital. J Infect 1996; 33: 23–32.
   PubMed Web of Science ®Google Scholar
• Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 1996; 23: 608–615.
   PubMed Web of Science ®Google Scholar
• Janssen JJ, Strack vSR, van der Poest Clement EH, Ossenkoppele GJ, Thijs LG, Huijgens PC. Outcome of ICU treatment in invasive aspergillosis. Intensive Care Med 1996; 22: 1315–1322.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary dis-ease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225–244.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Guidelines for prevention of nosocomial pneumonia. MMWR Morb Mortal Wkly Rep 1997; 46: 1–79.
   Google Scholar
• Elstad MR. Aspergillosis and lung defenses. Semin Respir Infect 1991; 6: 27–36.
   PubMedGoogle Scholar
• Duong - 1\4, Ouellet N, Simard M, Bergeron Y, Olivier M, Bergeron MG. Kinetic study of host defense and inflamma-tory response to Aspergillus fumigatus in steroid-induced immunosuppressed mice. J Infect Dis 1998; 178: 1472-1482.
   Google Scholar
• Ng TT, Robson GD, Denning DW. Hydrocortisone-enhanced growth of Aspergillus spp.: implications for patho-genesis. Microbiology 1994; 140 ( Pt 9): 2475-2479.
   Google Scholar
• Karam GH, Griffin FM. Invasive pulmonary aspergillo-sis in nonimmunocompromised, nonneutropenic hosts. Rev Infect Dis 1986; 8: 357–363.
   PubMedGoogle Scholar
• Tankanow L, Eichenhorn MS. Disseminated Strongyloides stercoralis and Aspergillus fumigatus present-ing as diffuse interstitial pneumonitis in a steroid-dependent chronic obstructive pulmonary disease patient. Henry Ford Hosp Med J 1988; 36: 41–43.
   PubMedGoogle Scholar
• Wiest PM, Flanigan T, Salata RA, Shlaes DM, Katzman M, Lederman MM. Serious infectious complications of corti-costeroid therapy for COPD. Chest 1989; 95: 1180–1184.
   PubMed Web of Science ®Google Scholar
• Thommi G, Bell G, Liu J, Nugent K. Spectrum of inva-sive pulmonary aspergillosis in immunocompetent patients with chronic obstructive pulmonary disease. South Med J 1991; 84: 828–831.
   PubMed Web of Science ®Google Scholar
• Crean JM, Niederman MS, Fein AM, Feinsilver SH. Rapidly progressive respiratory failure due to Aspergillus pneu-monia: a complication of short-term corticosteroid therapy. Crit Care Med 1992; 20: 148–150.
   PubMed Web of Science ®Google Scholar
• Conesa D, Rello J, Valles J, Mariscal D, Ferreres JC. Invasive aspergillosis: a life-threatening complication of short-term steroid treatment. Ann Pharmacother 1995; 29: 1235–1237.
   PubMed Web of Science ®Google Scholar
• Warnock DW. Fungal complications of transplantation: diagnosis, treatment and prevention. J Antimicrob Chemother 1995; 36 Suppl B: 73-90.
   Google Scholar
• Andriole VT. Infections with Aspergillus species. Clin Infect Dis 1993; 17 Suppl 2: S481–S486.
   PubMed Web of Science ®Google Scholar
• Gottfredsson M, Cox GM, Perfect JR. Molecular meth-ods for epidemiological and diagnostic studies of fungal infec-tions. Pathology 1998; 30: 405–418.
   PubMed Web of Science ®Google Scholar
• Reichenberger F, Habicht JM, Gratwohl A, Tamm M. Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients. Eur Respir J 2002; 19: 743–755.
   PubMed Web of Science ®Google Scholar
• Raad I, Hanna H, Huaringa A, Sumoza D, Hachem R, Albitar M. Diagnosis of invasive pulmonary aspergillosis using polymerase chain reaction-based detection of aspergillus in BAL. Chest 2002; 121: 1171–1176.
   PubMed Web of Science ®Google Scholar
• Donnelly JP. Symptoms and diagnosis of nosocomial fungal infections: State-of-the-art. Eur J Med Res 2002; 7: 192–199.
   PubMed Web of Science ®Google Scholar
• Marier R, Smith W, Jansen M, Andriole VT. A solid-phase radioimmunoassay for the measurement of antibody to Aspergillus in invasive aspergillosis. J Infect Dis 1979; 140: 771–779.
   PubMed Web of Science ®Google Scholar
• Swanink CM, Meis JF, Rijs AJ, Donnelly JP, Verweij PE. Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan. J Clin Microbiol 1997; 35: 257–260.
   PubMed Web of Science ®Google Scholar
• Andriole VT. Serodiagnosis of aspergillosis. In: Bennett JE, Hey RJ, Peterson PK, eds. New Strategies in Fungal Disease. New York: Churchill Livingstone. 1991: 245-256
   Google Scholar
• Franquet T, Muller NL, Gimenez A, Domingo P, Plaza V, Bordes R. Semiinvasive pulmonary aspergillosis in chronic obstructive pulmonary disease: radiologic and pathologic find-ings in nine patients. Am J Roentgenol 2000; 174: 51–56.
   PubMed Web of Science ®Google Scholar
• Flynn PM, Shenep JL, Crawford R, Hughes WT. Use of abdominal computed tomography for identifying disseminat-ed fungal infection in pediatric cancer patients. Clin Infect Dis 1995; 20: 964–970.
   PubMed Web of Science ®Google Scholar
• Caillot D, Casasnovas O, Bernard A et al. Improved management of invasive pulmonary aspergillosis in neu-tropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997; 15: 139–147.
   Google Scholar
• Subira M, Martino R, Franquet T et al. Invasive pul-monary aspergillosis in patients with hematologic malignan-cies: survival and prognostic factors. Haematologica 2002; 87: 528–534.
   Google Scholar
• Mills W, Chopra R, Linch DC, Goldstone AH. Liposomal amphotericin B in the treatment of fungal infec-tions in neutropenic patients: a single-centre experience of 133 episodes in 116 patients. Br J Haematol 1994; 86: 754–760.
   PubMed Web of Science ®Google Scholar
• Rodrigues J, Niederman MS, Fein AM, Pai PB. Nonresolving pneumonia in steroid-treated patients with obstructive lung disease. Am J Med 1992; 93: 29–34.
   PubMed Web of Science ®Google Scholar
• Pittet D, Huguenin T, Dharan S et al. Unusual cause of lethal pulmonary aspergillosis in patients with chronic obstruc-tive pulmonary disease. Am J Respir Crit Care Med 1996; 154: 541–544.
   Google Scholar
• Rello J, Esandi ME, Mariscal D, Gallego M, Domingo C, Valles J. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review. Clin Infect Dis 1998; 26: 1473–1475.
   PubMed Web of Science ®Google Scholar
• Bulpa PA, Dive AM, Garrino MG et al. Chronic obstructive pulmonary disease patients with invasive pul-monary aspergillosis: benefits of intensive care? Intensive Care Med 2001; 27: 59–67.
   PubMed Web of Science ®Google Scholar